Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylaxis of post-ERCP acute pancreatitis with indomethacin vs indomethacin plus Ringer lactate
2020-004298-35Phase 3Terminated
- Sponsor
- Santa Maria Nuova
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of indomethacin in pancreatitis (2 arms), sponsored by Santa Maria Nuova. Primary endpoint: Incidence of post-ERCP acute pancreatitis. Started Oct 2021; status: terminated.
02
Drugs
indomethacin
03
Conditions
pancreatitis
Beyond the preview
Go deeper on 2020-004298-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004298-35.